Your session is about to expire
← Back to Search
Fentanyl and Ticagrelor Interaction in Percutaneous Coronary Intervention (FACTPCI Trial)
FACTPCI Trial Summary
This trial suggests that Fentanyl may decrease the effectiveness of Ticagrelor, an anti-platelet agent used during PCI procedures.
FACTPCI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFACTPCI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 4 trial • 237 Patients • NCT01795898FACTPCI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for a procedure to open blocked arteries in my heart.You are pregnant.I have had or am scheduled for a valve replacement in my heart via catheter.I have been treated with blood thinners before a procedure.I haven't taken P2Y12 inhibitors in the last 14 days.I cannot take ticagrelor or opiates due to adverse reactions.I can take pills by mouth.I have a known blood clotting disorder.My kidney function is reduced.My liver isn't working properly.
- Group 1: Fentanyl and Crushed Ticagrelor
- Group 2: Fentanyl and Non-crushed Ticagrelor
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what cases is Fentanyl typically prescribed to treat?
"Fentanyl is a common anesthetic for conduction, yet can also effectively ease the symptoms of general anesthesia, stent placement, and cerebrovascular accident."
How many participants have signed up to partake in this research?
"Affirmative. Clinicaltrials.gov displays that this clinical experiment, which was first advertised on April 18th 2018, is currently recruiting patients. 80 individuals are required to be enrolled at 1 medical centre."
Has the FDA certified Fentanyl for therapeutic use?
"Fentanyl's safety is backed by clinical trials and has been approved, so it was given a score of 3."
What other experiments have explored the use of Fentanyl in clinical contexts?
"Currently, 83 clinical trials related to Fentanyl are underway with 21 of them in the late-stage. Of these studies, 667 research sites exist and many of them are located in Shenzhen, Guangdong."
Is participation in this experiment open to new volunteers?
"Clinicaltrials.gov reveals that this clinical trial is actively enrolling patients; the original posting was on April 18th 2018 and it has been edited for the last time on December 14th 2021."
Share this study with friends
Copy Link
Messenger